Market revenue in 2023 | USD 48.1 million |
Market revenue in 2030 | USD 115.5 million |
Growth rate | 13.3% (CAGR from 2023 to 2030) |
Largest segment | Regenerative medicine |
Fastest growing segment | Drug Discovery & Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regenerative Medicine, Drug Discovery & Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.44% in 2023. Horizon Databook has segmented the UK human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
UK stem cell bank was established 2003 for sharing and use of hESC for research and clinical applications. Research pertaining to hESCs and human embryos is controlled by the Human Fertilisation and Embryology Authority (HFEA).
Under the guidelines provided by the organisation, UK has advanced in stem cell research and innovated technology platform for clinical and heath application. iHuman, one such platform provides development of hESC for human health safety evaluation and application in regenerative medication.
Presence of organisations such as UK Stem Cell Bank (UKSCB), the Steering Committee for the Use of Stem Cell Lines, Stem Cell Oversight Committee (SCOC), and the Human Fertilisation and Embryology Authority (HFEA) in UK that provide guidelines and funding for stem cell research is expected to continue marking significant contributions to market growth in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UK human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into UK human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account